Other Events ·
DataMeds AI issues shares to REBOOT Health AI and settles $18.7M debt to restore Nasdaq equity compliance
MEDSDataMeds AI, Inc.
DataMeds AI entered into an IP License Agreement with REBOOT Health AI, issuing 666,667 restricted common stock shares valued at $2 million as consideration for exclusive licensing rights within its GLP-1 weight management business. The company also settled approximately $18.7 million of debt and converted $1.5 million in vendor payables into equity since April 2026. These transactions increased stockholders' equity to over $2.5 million, allowing the company to claim compliance with Nasdaq Listing Rule 5550(b)(1) minimum equity requirements following a deficiency notice received in April 2026. The filing is pending formal confirmation from Nasdaq regarding continued listing status on The Nasdaq Capital Market. DataMeds AI operates in the health technology sector, focusing on digital solutions for weight management and patient care.